Inflectra and Telmisartan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Inflectra (infliximab-dyyb) and Telmisartan (telmisartan). Common drug interactions include drug intolerance among females.
The phase IV clinical study analyzes what interactions people have when they take Inflectra and Telmisartan. It is created by eHealthMe based on reports of 126 people who take the same drugs from the FDA, and is updated regularly.
What is Inflectra?
Inflectra has active ingredients of infliximab-dyyb. eHealthMe is studying from 52,370 Inflectra users. Check the latest studies of Inflectra.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.
126 people who take Inflectra and Telmisartan together, and have interactions are studied.
What are the common drug interactions of Inflectra and Telmisartan, by gender? *
What are the common drug interactions of Inflectra and Telmisartan, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Inflectra and Telmisartan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Inflectra (52,370 reports)
- Telmisartan (9,163 reports)
Browse all drug interactions of Inflectra and Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Inflectra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Inflectra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Telmisartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on infliximab-dyyb and telmisartan (the active ingredients of Inflectra and Telmisartan, respectively), and Inflectra and Telmisartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cyproheptadine Hydrochloride and Sertraline - 5 seconds ago
- Drug interactions of Turmeric and Vitamin C - 13 seconds ago
- Chronic Lymphocytic Leukaemia and Cough - 21 seconds ago
- Drug interactions of Magnesium Oxide and Tasigna - 22 seconds ago
- Could Opana cause Drug Hypersensitivity? - 29 seconds ago
- Could Tamoxifen Citrate cause Hepatic Steatosis? - 35 seconds ago
- Could Ms Contin cause Hepatic Enzyme Increased? - 38 seconds ago
- Could Truvada cause Skin Exfoliation? - 39 seconds ago
- Could Metronidazole cause Pulmonary Tuberculosis? - 41 seconds ago
- Folic Acid vs. Micronor, side effect and effectiveness comparison - 42 seconds ago